PIRS

Pieris Pharmaceuticals, Inc.

1 day chart

About PIRS

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. The Company’s clinical pipeline includes an inhaled IL-4Ra antagonist Anticalin protein to treat asthma, an immuno-oncology (IO), bispecific targeting HER2 and 4-1BB, and an IO bispecific targeting PD-L1 and 4-1BB. Its lead respiratory Anticalin based drug candidate, elarekibep, antagonizes IL-4Ra, thereby inhibiting IL-4 and IL-13, two cytokines, which are small proteins mediating signaling between cells within the human body, known to be key mediators in the inflammatory cascade that drive the pathogenesis of asthma and other inflammatory diseases. Its IO portfolio also includes additional drug candidates beyond PRS-344/S095012 that are multi-specific Anticalin-based fusion proteins designed to engage immunomodulatory targets, comprising a variety of multifunctional biotherapeutics.

Buy US stocks in Australia starting with PIRS. Open an account and start investing today!

Market Capitalisation

$61.51M

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$0.82

Low today

$0.74

Open price

$0.00

52-week high

$2.12

52-week low

$0.72

PIRS FAQs

Can I buy PIRS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy PIRS shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Pieris Pharmaceuticals, Inc.?

One share of Pieris Pharmaceuticals, Inc. is valued at $0.75.

What is the ticker symbol for Pieris Pharmaceuticals, Inc.?

The ticker symbol for Pieris Pharmaceuticals, Inc. is PIRS.

How do I buy PIRS shares in Australia?

To buy PIRS stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in PIRS

What is the 52-week high for Pieris Pharmaceuticals, Inc. stock?

The Pieris Pharmaceuticals, Inc. 52-week high stock price is $2.12.

What is the 52-week low for Pieris Pharmaceuticals, Inc. stock?

The Pieris Pharmaceuticals, Inc. 52-week low stock price is $0.72.

What is the market capitalisation of Pieris Pharmaceuticals, Inc. PIRS?

As of 31/05/2023 Pieris Pharmaceuticals, Inc. has a market cap of $62M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.